BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 24022727)

  • 21. Mechanism-based genotoxicity screening of metal oxide nanoparticles using the ToxTracker panel of reporter cell lines.
    Karlsson HL; Gliga AR; Calléja FM; Gonçalves CS; Wallinder IO; Vrieling H; Fadeel B; Hendriks G
    Part Fibre Toxicol; 2014 Sep; 11():41. PubMed ID: 25179117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational context and diverse clonal development in early and late bladder cancer.
    Nordentoft I; Lamy P; Birkenkamp-Demtröder K; Shumansky K; Vang S; Hornshøj H; Juul M; Villesen P; Hedegaard J; Roth A; Thorsen K; Høyer S; Borre M; Reinert T; Fristrup N; Dyrskjøt L; Shah S; Pedersen JS; Ørntoft TF
    Cell Rep; 2014 Jun; 7(5):1649-1663. PubMed ID: 24835989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapse kinetics in acute myeloid leukaemias with MLL translocations or partial tandem duplications within the MLL gene.
    Ommen HB; Hokland P; Haferlach T; Abildgaard L; Alpermann T; Haferlach C; Kern W; Schnittger S
    Br J Haematol; 2014 Jun; 165(5):618-28. PubMed ID: 24611505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KRAS mutations: analytical considerations.
    Herreros-Villanueva M; Chen CC; Yuan SS; Liu TC; Er TK
    Clin Chim Acta; 2014 Apr; 431():211-20. PubMed ID: 24534449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of haematological parameters and serum tumour markers for predicting KRAS mutations in 784 Chinese colorectal cancer patients: a retrospective analysis.
    Cao Y; Gu J; Yan L; Deng S; Mao F; Cai W; Li H; Liu X; Wang J; Wu K; Cai K
    BMC Cancer; 2020 Nov; 20(1):1099. PubMed ID: 33183271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repurposing EGFR Inhibitor Utility in Colorectal Cancer in Mutant
    Yang M; Schell MJ; Loboda A; Nebozhyn M; Li J; Teer JK; Pledger WJ; Yeatman TJ
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1141-1152. PubMed ID: 31015202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review.
    García-Foncillas J; Alba E; Aranda E; Díaz-Rubio E; López-López R; Tabernero J; Vivancos A
    Ann Oncol; 2017 Dec; 28(12):2943-2949. PubMed ID: 28945877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RAS mutation prevalence among patients with metastatic colorectal cancer: a meta-analysis of real-world data.
    Kafatos G; Niepel D; Lowe K; Jenkins-Anderson S; Westhead H; Garawin T; Traugottová Z; Bilalis A; Molnar E; Timar J; Toth E; Gouvas N; Papaxoinis G; Murray S; Mokhtar N; Vosmikova H; Fabian P; Skalova A; Wójcik P; Tysarowski A; Barugel M; van Krieken JH; Trojan J
    Biomark Med; 2017 Sep; 11(9):751-760. PubMed ID: 28747067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR.
    Della Corte CM; Malapelle U; Vigliar E; Pepe F; Troncone G; Ciaramella V; Troiani T; Martinelli E; Belli V; Ciardiello F; Morgillo F
    Oncotarget; 2017 Apr; 8(14):23020-23032. PubMed ID: 28416737
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Lee SH; Chung AM; Lee A; Oh WJ; Choi YJ; Lee YS; Jung ES
    J Pathol Transl Med; 2017 Jan; 51(1):24-31. PubMed ID: 28013534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres.
    Boleij A; Tack V; Taylor A; Kafatos G; Jenkins-Anderson S; Tembuyser L; Dequeker E; van Krieken JH
    BMC Cancer; 2016 Oct; 16(1):825. PubMed ID: 27784278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer.
    Omolo B; Yang M; Lo FY; Schell MJ; Austin S; Howard K; Madan A; Yeatman TJ
    BMC Med Genomics; 2016 Oct; 9(1):65. PubMed ID: 27756306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single Synonymous Mutations in KRAS Cause Transformed Phenotypes in NIH3T3 Cells.
    Waters AM; Bagni R; Portugal F; Hartley JL
    PLoS One; 2016; 11(9):e0163272. PubMed ID: 27684555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal Cancer.
    Rankin A; Klempner SJ; Erlich R; Sun JX; Grothey A; Fakih M; George TJ; Lee J; Ross JS; Stephens PJ; Miller VA; Ali SM; Schrock AB
    Oncologist; 2016 Nov; 21(11):1306-1314. PubMed ID: 27682134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of MCRS1 and MCRS2 and their correlation with serum carcinoembryonic antigen in colorectal cancer.
    Li C; Chen M; Zhao P; Ayana DA; Wang L; Jiang Y
    Exp Ther Med; 2016 Aug; 12(2):589-596. PubMed ID: 27446248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases.
    Malapelle U; Pisapia P; Sgariglia R; Vigliar E; Biglietto M; Carlomagno C; Giuffrè G; Bellevicine C; Troncone G
    J Clin Pathol; 2016 Sep; 69(9):767-71. PubMed ID: 26797410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eprobe-mediated screening system for somatic mutations in the KRAS locus.
    Atsumi J; Hanami T; Enokida Y; Ogawa H; Delobel D; Mitani Y; Kimura Y; Soma T; Tagami M; Takase Y; Ichihara T; Takeyoshi I; Usui K; Hayashizaki Y; Shimizu K
    Oncol Rep; 2015 Jun; 33(6):2719-27. PubMed ID: 25823645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer in iran: molecular epidemiology and screening strategies.
    Dolatkhah R; Somi MH; Bonyadi MJ; Asvadi Kermani I; Farassati F; Dastgiri S
    J Cancer Epidemiol; 2015; 2015():643020. PubMed ID: 25685149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of KRAS mutation analysis of colorectal cancer samples by standard testing and next-generation sequencing.
    Kothari N; Schell MJ; Teer JK; Yeatman T; Shibata D; Kim R
    J Clin Pathol; 2014 Sep; 67(9):764-7. PubMed ID: 25004944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs and beyond.
    Malapelle U; Carlomagno C; de Luca C; Bellevicine C; Troncone G
    J Clin Pathol; 2014 Jan; 67(1):1-9. PubMed ID: 24022727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.